GlyCardial Diagnostics wins the EmprendedorXXI 2019 Award in the ‘Health Tech’ category Blog Post

GlyCardial Diagnostics has won the  the EmprendedorXXI Award in the ‘Health Tech’ category, one of the six awards granted in its twelfth year to recognize those companies in Spain and Portugal with greatest growth potential in several sectors linked to the new innovation trends. The winners have been selected from 961 companies in Spain and Portugal. The biotechnology company, headquartered in the Barcelona Science Park, adds this award to the EmprendedorXXI Award in Catalonia, which it received on 9 May.

 

Avizorex receives the EntrepreneurXXI Award in the Lifes Science category Blog Post

Today, the Caixaforum auditorium in Barcelona has hosted the 10th EmprendedorXXI Awards Ceremony, an initiative promoted by “la Caixa”, through Caixa Capital Risc, and co-awarded by the Ministry of Economy, Industry and Competitiveness, through Enisa.The biotechnology company, Avizorex Pharma, an ophthalmology biotech company with offices at Barcelona Science Park (PCB), has received the award in the Life Sciences category.

 

Intelligent Pharma wins the award CaràcterEmpresa to Innovation in Catalonia Blog Post

Intelligent Pharma, a company based at the Barcelona Science Park  (PCB), has won the Premi CaràcterEmpresa award in the category of Innovation among 14 companies from around Catalonia and has been selected to take part in the nation-wide final phase, that will take place this coming June. The CaràcterEmpresa awards are promoted by CaixaBank and by the Spanish Confederatiion of Business Organizations (CEOE) in the Catalan edition, also promoted by Foment del Treball, the institution representing the interests of Catalan industry and business.

The Ordesa Foundation allocates 300,000 euros to charity projects for disadvantaged children Blog Post

The Ordesa Foundation has given the Ordesa 2015 grants, endowed with a total of 300,000 euros. A large part of this amount will be allocated to six projects aimed to address the most disadvantaged childhood and motherhood population in the world. As a novelty, this edition has added a new category aimed at twenty initiatives aimed at children at social risk in Spain which will receive a grant of 5,000 euros each. This´s year call will also donate 10 tons of baby food to social institutions that cater to families without resources. Since 2007 Ordesa has a R+D+I Center at PCB from which it takes an active role in clinical studies and national and international programs to improve the health and quality of citizens, especially during the maternal-child stage. 

 

Home Page

  Artistic contributions at the Barcelona Science Park   Strategic Plan 2025-2030   Wide technological offer and high added value services   High-quality spaces and facilities   Parc Científic de...

Judit Cubedo, CEO of GlyCardial, finalist for the EU Prize for Women Innovators 2020 Blog Post

Judit Cubedo, co-founder and CEO of GlyCardial Diagnostics, is one of the twenty-one women selected as finalists for the EU Prize for Women Innovators 2020, an award given annually to the most talented and inspiring entrepreneurs in Europe. The company led by Judit, which is based in the Barcelona Science Park, is conducting a clinical trial to validate the performance of Apo J-Glyc as a novel biomarker for the early detection of Myocardial Ischaemia. The award winners will be announced at the European Research and Innovation Days taking place on 22-24 September 2020.